Title

蟾毒靈影響人類非小細胞肺癌NCI-H460產生細胞凋亡和轉移之研究

Translated Titles

Studies on the Effects of Bufalin on Apoptosis and Metastasis of NCI-H460 cells

DOI

10.6830/CMU.2014.00010

Authors

吳莘華

Key Words

apopptosis ; bufalin ; carcinoma, non-small cell lung ; DNA damage ; microarray analysis ; metastasis ; 細胞凋亡 ; 蟾毒靈 ; 非小細胞肺癌 ; DNA損傷 ; 微晶片分析 ; 轉移

PublicationName

中國醫藥大學臨床醫學研究所博士班 學位論文

Volume or Term/Year and Month of Publication

2014年

Academic Degree Category

博士

Advisor

徐武輝

Content Language

繁體中文

Topic Category 醫藥衛生 > 社會醫學
醫學院 > 臨床醫學研究所博士班
Reference
  1. Akhter, S., C. T. Richie, J. M. Deng, E. Brey, X. Zhang, C. Patrick, Jr., R. R. Behringer and R. J. Legerski (2004). "Deficiency in SNM1 abolishes an early mitotic checkpoint induced by spindle stress." Mol Cell Biol 24(23): 10448-10455.
    連結:
  2. Audeh, M. W., J. Carmichael, R. T. Penson, M. Friedlander, B. Powell, K. M. Bell-McGuinn, C. Scott, J. N. Weitzel, A. Oaknin, N. Loman, K. Lu, R. K. Schmutzler, U. Matulonis, M. Wickens and A. Tutt (2010). "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial." Lancet 376(9737): 245-251.
    連結:
  3. Basu, B., T. A. Yap, L. R. Molife and J. S. de Bono (2012). "Targeting the DNA damage response in oncology: past, present and future perspectives." Curr Opin Oncol 24(3): 316-324.
    連結:
  4. Bryant, H. E., N. Schultz, H. D. Thomas, K. M. Parker, D. Flower, E. Lopez, S. Kyle, M. Meuth, N. J. Curtin and T. Helleday (2005). "Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase." Nature 434(7035): 913-917.
    連結:
  5. Carragher, N. O., M. A. Westhoff, V. J. Fincham, M. D. Schaller and M. C. Frame (2003). "A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src." Curr Biol 13(16): 1442-1450.
    連結:
  6. Chan, T. A., H. Hermeking, C. Lengauer, K. W. Kinzler and B. Vogelstein (1999). "14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage." Nature 401(6753): 616-620.
    連結:
  7. Chaturvedi, M. M., B. Sung, V. R. Yadav, R. Kannappan and B. B. Aggarwal (2011). "NF-kappaB addiction and its role in cancer: 'one size does not fit all'." Oncogene 30(14): 1615-1630.
    連結:
  8. Chen, A., J. Yu, L. Zhang, Y. Sun, Y. Zhang, H. Guo, Y. Zhou, K. Mitchelson and J. Cheng (2009). "Microarray and biochemical analysis of bufalin-induced apoptosis of HL-60 Cells." Biotechnol Lett 31(4): 487-494.
    連結:
  9. Chen, Y. Y., H. F. Lu, S. C. Hsu, C. L. Kuo, S. J. Chang, J. J. Lin, P. P. Wu, J. Y. Liu, C. H. Lee, J. G. Chung and J. B. Chang (2013). "Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways." Environ Toxicol.
    連結:
  10. Christmann, M., B. Verbeek, W. P. Roos and B. Kaina (2011). "O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry." Biochim Biophys Acta 1816(2): 179-190.
    連結:
  11. Coussens, L. M., B. Fingleton and L. M. Matrisian (2002). "Matrix metalloproteinase inhibitors and cancer: trials and tribulations." Science (New York, N.Y.) 295(5564): 2387-2392.
    連結:
  12. del Barco Barrantes, I. and A. R. Nebreda (2012). "Roles of p38 MAPKs in invasion and metastasis." Biochem Soc Trans 40(1): 79-84.
    連結:
  13. Farmer, H., N. McCabe, C. J. Lord, A. N. Tutt, D. A. Johnson, T. B. Richardson, M. Santarosa, K. J. Dillon, I. Hickson, C. Knights, N. M. Martin, S. P. Jackson, G. C. Smith and A. Ashworth (2005). "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy." Nature 434(7035): 917-921.
    連結:
  14. Gu, W., K. Q. Han, Y. H. Su, X. Q. Huang and C. Q. Ling (2007). "[Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice]." Zhong Xi Yi Jie He Xue Bao 5(2): 155-159.
    連結:
  15. Han, K. Q., G. Huang, W. Gu, Y. H. Su, X. Q. Huang and C. Q. Ling (2007). "Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice." World J Gastroenterol 13(24): 3374-3379.
    連結:
  16. Hashimoto, S., Y. Jing, N. Kawazoe, Y. Masuda, S. Nakajo, T. Yoshida, Y. Kuroiwa and K. Nakaya (1997). "Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs." Leuk Res 21(9): 875-883.
    連結:
  17. Hsu, Y. T. and R. J. Youle (1998). "Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations." J Biol Chem 273(17): 10777-10783.
    連結:
  18. Huang, H., Y. Cao, W. Wei, W. Liu, S. Y. Lu, Y. B. Chen, Y. Wang, H. Yan and Y. L. Wu (2013). "Targeting poly (adp-ribose) polymerase partially contributes to bufalin-induced cell death in multiple myeloma cells." PLoS One 8(6): e66130.
    連結:
  19. Huber, M. A., H. Beug and T. Wirth (2004). "Epithelial-mesenchymal transition: NF-kappaB takes center stage." Cell Cycle 3(12): 1477-1480.
    連結:
  20. Igawa, T., Y. Sato, K. Takata, S. Fushimi, M. Tamura, N. Nakamura, Y. Maeda, Y. Orita, M. Tanimoto and T. Yoshino (2011). "Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma." Cancer Sci 102(11): 2103-2107.
    連結:
  21. Jiang, Y., Y. Zhang, J. Luan, H. Duan, F. Zhang, K. Yagasaki and G. Zhang (2010). "Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action." Cytotechnology 62(6): 573-583.
    連結:
  22. Kawase, T., H. Ichikawa, T. Ohta, N. Nozaki, F. Tashiro, R. Ohki and Y. Taya (2008). "p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis." Oncogene 27(27): 3797-3810.
    連結:
  23. Kawazoe, N., T. Aiuchi, Y. Masuda, S. Nakajo and K. Nakaya (1999). "Induction of apoptosis by bufalin in human tumor cells is associated with a change of intracellular concentration of Na+ ions." J Biochem 126(2): 278-286.
    連結:
  24. Kim, D., S. Kim, H. Koh, S. O. Yoon, A. S. Chung, K. S. Cho and J. Chung (2001). "Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production." FASEB J 15(11): 1953-1962.
    連結:
  25. Kim, H. J., N. Hawke and A. S. Baldwin (2006). "NF-kappaB and IKK as therapeutic targets in cancer." Cell Death Differ 13(5): 738-747.
    連結:
  26. Koyama-Nasu, R., Y. Nasu-Nishimura, T. Todo, Y. Ino, N. Saito, H. Aburatani, K. Funato, K. Echizen, H. Sugano, R. Haruta, M. Matsui, R. Takahashi, E. Manabe, T. Oda and T. Akiyama (2013). "The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells." Oncogene 32(33): 3840-3845.
    連結:
  27. Lee, J. H., Y. A. Koh, C. K. Cho, S. J. Lee, Y. S. Lee and S. Bae (2005). "Identification of a novel ionizing radiation-induced nuclease, AEN, and its functional characterization in apoptosis." Biochem Biophys Res Commun 337(1): 39-47.
    連結:
  28. Lemasters, J. J. (2005). "Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis." Gastroenterology 129(1): 351-360.
    連結:
  29. Li, D., X. Qu, K. Hou, Y. Zhang, Q. Dong, Y. Teng, J. Zhang and Y. Liu (2009). "PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells." Anticancer Drugs 20(1): 59-64.
    連結:
  30. Li, Z. and Z. Li (2012). "Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks." Biochim Biophys Acta 1826(1): 13-22.
    連結:
  31. Liang, Y., S. Y. Lin, F. C. Brunicardi, J. Goss and K. Li (2009). "DNA damage response pathways in tumor suppression and cancer treatment." World J Surg 33(4): 661-666.
    連結:
  32. Liu, S. C., D. E. Bassi, S. Y. Zhang, D. Holoran, C. J. Conti and A. J. Klein-Szanto (2002). "Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells." Mol Carcinog 34(3): 131-139.
    連結:
  33. Lu, C. X., K. J. Nan and Y. Lei (2008). "Agents from amphibians with anticancer properties." Anticancer Drugs 19(10): 931-939.
    連結:
  34. Luo, K., J. Yuan and Z. Lou (2011). "Oligomerization of MDC1 protein is important for proper DNA damage response." J Biol Chem 286(32): 28192-28199.
    連結:
  35. Masuda, Y., N. Kawazoe, S. Nakajo, T. Yoshida, Y. Kuroiwa and K. Nakaya (1995). "Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells." Leuk Res 19(8): 549-556.
    連結:
  36. Matthews, T. P., A. M. Jones and I. Collins (2013). "Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies." Expert Opin Drug Discov 8(6): 621-640.
    連結:
  37. McCawley, L. J., S. Li, E. V. Wattenberg and L. G. Hudson (1999). "Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration." J Biol Chem 274(7): 4347-4353.
    連結:
  38. Meng, Z., P. Yang, Y. Shen, W. Bei, Y. Zhang, Y. Ge, R. A. Newman, L. Cohen, L. Liu, B. Thornton, D. Z. Chang, Z. Liao and R. Kurzrock (2009). "Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer." Cancer 115(22): 5309-5318.
    連結:
  39. Molina, J. R., A. A. Adjei and J. R. Jett (2006). "ADvances in chemotherapy of non-small cell lung cancer*." CHEST Journal 130(4): 1211-1219.
    連結:
  40. Narumiya, S., M. Tanji and T. Ishizaki (2009). "Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion." Cancer Metastasis Rev 28(1-2): 65-76.
    連結:
  41. Parkin, D. M., F. Bray, J. Ferlay and P. Pisani (2005). "Global cancer statistics, 2002." CA Cancer J Clin 55(2): 74-108.
    連結:
  42. Pastor, N. and F. Cortes (2003). "Bufalin influences the repair of X-ray-induced DNA breaks in Chinese hamster cells." DNA Repair (Amst) 2(12): 1353-1360.
    連結:
  43. Pastor, N., I. Dominguez, S. Mateos and F. Cortes (2002). "A comparative study of genotoxic effects of anti-topoisomerase II drugs ICRF-193 and bufalin in Chinese hamster ovary cells." Mutat Res 515(1-2): 171-180.
    連結:
  44. Prasad, S., J. Ravindran and B. B. Aggarwal (2010). "NF-kappaB and cancer: how intimate is this relationship." Mol Cell Biochem 336(1-2): 25-37.
    連結:
  45. Qin, T. J., X. H. Zhao, J. Yun, L. X. Zhang, Z. P. Ruan and B. R. Pan (2008). "Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma." World J Gastroenterol 14(33): 5210-5216.
    連結:
  46. Richie, C. T., C. Peterson, T. Lu, W. N. Hittelman, P. B. Carpenter and R. J. Legerski (2002). "hSnm1 colocalizes and physically associates with 53BP1 before and after DNA damage." Mol Cell Biol 22(24): 8635-8647.
    連結:
  47. Roos, W. P. and B. Kaina (2013). "DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis." Cancer Lett 332(2): 237-248.
    連結:
  48. Siegel, R., D. Naishadham and A. Jemal (2013). "Cancer statistics, 2013." CA Cancer J Clin 63(1): 11-30.
    連結:
  49. Spiro, S. G. and G. A. Silvestri (2005). "One Hundred Years of Lung Cancer." American Journal of Respiratory and Critical Care Medicine 172(5): 523-529.
    連結:
  50. Takai, N., T. Ueda, M. Nishida, K. Nasu and H. Narahara (2008). "Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells." Int J Mol Med 21(5): 637-643.
    連結:
  51. Tanno, S., S. Tanno, Y. Mitsuuchi, D. A. Altomare, G. H. Xiao and J. R. Testa (2001). "AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells." Cancer Res 61(2): 589-593.
    連結:
  52. Tomek, M., T. Akiyama and C. R. Dass (2012). "Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy." J Pharm Pharmacol 64(12): 1695-1702.
    連結:
  53. Tutt, A., M. Robson, J. E. Garber, S. M. Domchek, M. W. Audeh, J. N. Weitzel, M. Friedlander, B. Arun, N. Loman, R. K. Schmutzler, A. Wardley, G. Mitchell, H. Earl, M. Wickens and J. Carmichael (2010). "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial." Lancet 376(9737): 235-244.
    連結:
  54. Vairapandi, M., A. G. Balliet, B. Hoffman and D. A. Liebermann (2002). "GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress." J Cell Physiol 192(3): 327-338.
    連結:
  55. Verbeek, B., T. D. Southgate, D. E. Gilham and G. P. Margison (2008). "O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy." Br Med Bull 85: 17-33.
    連結:
  56. Viala, E. and J. Pouyssegur (2004). "Regulation of tumor cell motility by ERK mitogen-activated protein kinases." Ann N Y Acad Sci 1030: 208-218.
    連結:
  57. Watabe, M., Y. Masuda, S. Nakajo, T. Yoshida, Y. Kuroiwa and K. Nakaya (1996). "The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells." J Biol Chem 271(24): 14067-14072.
    連結:
  58. Xie, X. B., J. Q. Yin, L. L. Wen, Z. H. Gao, C. Y. Zou, J. Wang, G. Huang, Q. L. Tang, C. Colombo, W. L. He, Q. Jia and J. N. Shen (2012). "Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research." PLoS One 7(10): e47375.
    連結:
  59. Yin, J. Q., J. N. Shen, W. W. Su, J. Wang, G. Huang, S. Jin, Q. C. Guo, C. Y. Zou, H. M. Li and F. B. Li (2007). "Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines." Acta Pharmacol Sin 28(5): 712-720.
    連結:
  60. Yoon, S. O., S. J. Park, C. H. Yun and A. S. Chung (2003). "Roles of matrix metalloproteinases in tumor metastasis and angiogenesis." J Biochem Mol Biol 36(1): 128-137.
    連結:
  61. Yu, C. H., S. F. Kan, H. F. Pu, E. Jea Chien and P. S. Wang (2008). "Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells." Cancer Sci 99(12): 2467-2476.
    連結:
  62. Zenmyo, M., A. Tanimoto, H. Sakakima, M. Yokouchi, S. Nagano, T. Yamamoto, Y. Ishido, S. Komiya and K. Ijiri (2010). "Gadd45beta expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading." Diagn Pathol 5: 69.
    連結:
  63. Zhu, Z., H. Sun, G. Ma, Z. Wang, E. Li, Y. Liu and Y. Liu (2012). "Bufalin Induces Lung Cancer Cell Apoptosis via the Inhibition of PI3K/Akt Pathway." Int J Mol Sci 13(2): 2025-2035.
    連結:
  64. Zumbrun, S. D., B. Hoffman and D. A. Liebermann (2009). "Distinct mechanisms are utilized to induce stress sensor gadd45b by different stress stimuli." J Cell Biochem 108(5): 1220-1231.
    連結:
  65. Cao, H., T. Shibayama-Imazu, Y. Masuda, T. Shinki, S. Nakajo and K. Nakaya (2007). "Involvement of Tiam1 in apoptosis induced by bufalin in HeLa cells." Anticancer Res 27(1A): 245-249.
  66. Horn, L., R. Eisenberg, D. Gius, K. N. Kimmelshue, P. P. Massion, J. B. Putnam, C. G. Robinson and D. P. Carbone (2014). Cancer of the Lung. Abeloff's Clinical Oncology. J. E. Niederhuber, J. O. Armitage, J. H. Doroshow, M. B. Kastan and J. E. Tepper, Churchill Livingstone, an imprint of Elsevier Inc.: 1143-1192.e1113.
  67. Jia, W., X. J. Gao, Z. D. Zhang, Z. X. Yang and G. Zhang (2013). "S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF." Eur Rev Med Pharmacol Sci 17(11): 1495-1508.
  68. Jungmichel, S., J. A. Clapperton, J. Lloyd, F. J. Hari, C. Spycher, L. Pavic, J. Li, L. F. Haire, M. Bonalli, D. H. Larsen, C. Lukas, J. Lukas, D. MacMillan, M. L. Nielsen, M. Stucki and S. J. Smerdon (2012). "The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator." Nucleic Acids Res 40(9): 3913-3928.
  69. Korsmeyer, S. J., J. R. Shutter, D. J. Veis, D. E. Merry and Z. N. Oltvai (1993). "Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death." Semin Cancer Biol 4(6): 327-332.
  70. Mansfield, P. J., J. A. Shayman and L. A. Boxer (2000). "Regulation of polymorphonuclear leukocyte phagocytosis by myosin light chain kinase after activation of mitogen-activated protein kinase." Blood 95(7): 2407-2412.
  71. Pepper, W. (1850). "Cases of cancer of the lung and mediastinum." Trans Coll Physicians Phila 1: 96-110.
  72. Shuman Moss, L. A., S. Jensen-Taubman and W. G. Stetler-Stevenson (2012). "Matrix metalloproteinases: changing roles in tumor progression and metastasis." Am J Pathol 181(6): 1895-1899.
  73. Weyhenmeyer, B., A. C. Murphy, J. H. Prehn and B. M. Murphy (2012). "Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer." Exp Oncol 34(3): 192-199.
  74. 尹立華 (2007). "蟾酥注射液聯合化療治療晚期非小細胞肺癌療效觀察." 遼寧中醫雜志(04): 440-441.
  75. 百度公司. "蟾酥." 百度百科 Retrieved Sep. 20, 2010, from http://baike.baidu.com/view/122114.htm.
  76. 余椿生 (2008). "蟾酥." 食品與藥品(01): 73-75.
  77. 范鈺, 鄭樹 and 趙剛 (2006). "蟾蜍靈對結腸癌SW-480细胞polo-like kinase-1表達及细胞凋亡的影響." 中國病理生理雜誌(22卷3期): 4.
  78. 祝銀梅, 田鴻生, 王典義 and 高文琴 (1989). "蟾酥對大鼠氣管體外誘癌與雞胚皮膚接觸培養的抑癌作用觀察." 中西醫結合雜誌 9(1): 29-30.
  79. 陳同生, 王小平, 孫磊, 王會營 and 王龍祥 (2008). "Caspase-3參與調控蟾酥誘導人肺腺癌(ASTC-a-1)細胞的凋亡." 生物化學與生物物理進展(01): 85-90.
  80. 趙建清, 邢立強, 李旺, 張淑平, 李桂林 and 錢海紅 (2006). "蟾酥注射液聯合化療治療晚期非小細胞肺癌的臨床研究." 時珍國醫國藥(08): 1604-1605.
  81. 劉俊珊, 張冬梅, 栗原博 and 葉文才 (2009). "蟾酥及其活性成分抗腫瘤作用研究進展." 國際藥學研究雜志(02): 115-120.